Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
Qiagen NV (NYSE: QGEN) closed the day trading at $41.15 down -2.28% from the previous closing price of $42.11. In other words, the price has decreased by -$2.28 from its previous closing price. On the day, 1.78 million shares were traded. QGEN stock price reached its highest trading level at $42.55 during the session, while it also had its lowest trading level at $41.13.
Ratios:
For a better understanding of QGEN, let’s look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 9.23 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 17.59. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 3.37. In the meantime, Its Debt-to-Equity ratio is 0.41 whereas as Long-Term Debt/Eq ratio is at 0.40.
On February 19, 2025, Robert W. Baird Downgraded its rating to Neutral which previously was Outperform and also lowered its target price recommendation from $52 to $42.
Morgan Stanley Downgraded its Overweight to Equal-Weight on January 06, 2025, while the target price for the stock was maintained at $48.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Sep 11 ’24 when Sackers Roland bought 25,000 shares for $46.00 per share.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, QGEN now has a Market Capitalization of 8911280128 and an Enterprise Value of 9350902784. As of this moment, Qiagen’s Price-to-Earnings (P/E) ratio for their current fiscal year is 98.59, and their Forward P/E ratio for the next fiscal year is 16.34. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 13.60. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.44 while its Price-to-Book (P/B) ratio in mrq is 2.61. Its current Enterprise Value per Revenue stands at 4.669 whereas that against EBITDA is 13.326.
Stock Price History:
The Beta on a monthly basis for QGEN is 0.65, which has changed by -0.105240285 over the last 52 weeks, in comparison to a change of 0.11241627 over the same period for the S&P500. Over the past 52 weeks, QGEN has reached a high of $47.92, while it has fallen to a 52-week low of $37.63. The 50-Day Moving Average of the stock is 0.90%, while the 200-Day Moving Average is calculated to be -4.56%.
Shares Statistics:
Over the past 3-months, QGEN traded about 1.33M shares per day on average, while over the past 10 days, QGEN traded about 1588770 shares per day. A total of 216.56M shares are outstanding, with a floating share count of 214.41M. Insiders hold about 0.79% of the company’s shares, while institutions hold 71.69% stake in the company. Shares short for QGEN as of 1745971200 were 5044426 with a Short Ratio of 3.78, compared to 1743379200 on 4044375. Therefore, it implies a Short% of Shares Outstanding of 5044426 and a Short% of Float of 3.47.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.005936832The current Payout Ratio is 0.00% for QGEN, which recently paid a dividend on 2024-01-30 with an ex-dividend date of 1751414400. Stock splits for the company last occurred on 2017-01-25 when the company split stock in a 962:1000 ratio.
